Social Clips

Study of Potencial Cell Therapy Treated its 20th Patient

Cytori Therapeutics recently announced that its Phase 3 STAR clinical trial, evaluating the efficacy and safety of Cytori Cell Therapy in scleroderma patients with hand impairment, has treated its 20th patient to reach 25 percent of its enrollment and treatment goal. The trial is continuing on the recommendation of an independent monitoring committee that evaluated safety data…

Scleroderma and Lupus Research with Dr. Anne Stevens

In this video by the Arthritis National Research Foundation, meet Anne Stevens, MD, PhD, who is one of the world’s leading researchers in scleroderma and lupus research. Her autoimmune research is paving the way for new treatments for patients with scleroderma, lupus and related autoimmune diseases.

Last Week’s Hot Topic on Scleroderma

Last week’s hot topic on Scleroderma was Pulmonary Hypertension Prevented, Treated by Macitentan in Systemic Sclerosis Mouse Model written by Magdalena Kegel. This article is about a study which showed that macitentan (Opsumit) can prevent pulmonary arterial hypertension (PAH) in a mouse model of…

#SSc16 – Exclusive Interview with Christopher Denton, BAYER

https://sclerodermanews.com/wp-content/uploads/videos/Sequence%2001_1.mp4 Scleroderma News correspondent Dr. Ana de Barros has conducted an exclusive interview with Prof. Christopher Denton, the lead investigator in a Bayer’s clinical trial, at the 4th Systemic Sclerosis World Congress, currently underway in Lisbon, Portugal. Stay tuned for a feature article and complete interview.

#SSc16 Program and Hours

The 4th Systemic Sclerosis World Congress, organized by the World Scleroderma Foundation (WSF), will run Feb. 18–20 at the Lisbon Congress Center in Lisbon, Portugal, and Scleroderma News Today will be there to cover and report on the proceedings Experts with…

Systemic Sclerosis World Conference: We are here

This year, Scleroderma News will be offering live, on-site coverage of the 4th Systemic Sclerosis World Conference in Lisbon, Portugal, from February 18-20. Follow everything through the #SSc16 #SclerodermaNews on our Facebook, Twitter, our exclusive board on Pinterest and here: https://bit.ly/1Ts2X9H…